WACKER SILICONES
WACKER SILICONES generated substantial sales growth in 2018. Sales climbed 13.6 percent to €2.50 billion (2017: €2.20 billion). The main factors were markedly higher volumes for specialty products – coupled with a correspondingly better product mix – and higher prices. Many different market segments spurred this growth, including electronics, construction and medical technology. WACKER SILICONES posted robust sales gains in all of its three main regions: Europe, the Americas and Asia.
EBITDA outpaced sales growth year over year, rising by 38.6 percent to €616.6 million (2017: €444.9 million). It was driven by strong volume growth, higher prices and high plant utilization rates. The EBITDA margin was 24.7 percent, considerably higher than a year earlier (2017: 20.2 percent).
Capital expenditures climbed by 56.0 percent year over year to €222.7 million (2017: €142.8 million). The main investment projects were the construction of a new pyrogenic silica plant at Charleston (USA), the expansion of silicon-metal production at Holla (Norway), and new facilities for downstream silicone products at Burghausen (Germany) and Zhangjiagang (China). As of December 31, 2018, the division had 5,114 employees (Dec. 31, 2017: 4,737).
Download XLS |
|
|
|
||||||||||
€ million |
2018 |
2017 |
20161 |
2015 |
2014 |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
|
||||||||||||
|
|
|
|
|
|
|||||||
Total sales |
2,499.6 |
2,200.2 |
2,001.1 |
1,943.3 |
1,733.6 |
|||||||
EBITDA |
616.6 |
444.9 |
361.2 |
276.2 |
209.8 |
|||||||
EBITDA margin (%) |
24.7 |
20.2 |
18.1 |
14.2 |
12.1 |
|||||||
EBIT |
536.7 |
362.2 |
280.8 |
194.5 |
128.9 |
|||||||
Capital expenditures |
222.7 |
142.8 |
88.6 |
82.0 |
88.5 |
|||||||
R&D expenses |
60.9 |
58.6 |
53.7 |
35.8 |
39.5 |
|||||||
Employees (December 31, number) |
5,114 |
4,737 |
4,566 |
4,353 |
4,240 |